Atlas Trials

Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis

Clinical trial NCT01362504 · COMPLETED

Trial details

NCT number
NCT01362504
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Sepsis
Start date
2011-05-01
Primary completion
2011-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.